Common Contracts
2 similar Advisory Services Agreement contracts by Semnur Pharmaceuticals, Inc.
ADVISORY SERVICES AGREEMENTAdvisory Services Agreement • November 6th, 2024 • Semnur Pharmaceuticals, Inc. • Blank checks • Delaware
THIS CONSULTING SERVICES AGREEMENT (this “Agreement”), is dated August 25, 2024 (the “Effective Date”), by and between SEMNUR PHARMACEUTICALS, INC., a Delaware corporation, having a principal place of business at 960 San Antonio Road, Suite 200, Palo Alto, CA 94303 (“Semnur” or the “Company”) and 450W42ND MIMA, LLC, having a principal place of business or address at 450 West 42nd Street PH 1C, New York, NY 10036 (“Consultant” or “Stockholder”). Semnur and Consultant may be referred to herein individually as a “party” or, collectively, as the “parties”.
ADVISORY SERVICES AGREEMENTAdvisory Services Agreement • November 6th, 2024 • Semnur Pharmaceuticals, Inc. • Blank checks • Delaware
THIS CONSULTING SERVICES AGREEMENT (this “Agreement”), is dated August 26, 2024 (the “Effective Date”), by and between SEMNUR PHARMACEUTICALS, INC., a Delaware corporation, having a principal place of business at 960 San Antonio Road, Suite 200, Palo Alto, CA 94303 (“Semnur” or the “Company”) and Wise Orient Investments Limited, having a principal place of business or address at Central Park Palaza Room 903-1, No. 10 Chaoyang Park South Road, Beijing, China (“Consultant” or “Stockholder”). Semnur and Consultant may be referred to herein individually as a “party” or, collectively, as the “parties”.
